Results 111 to 120 of about 3,242 (120)

Chiral auxiliaries as docking/protecting groups: biohydroxylation of selected ketones with Beauveria bassiana ATCC 7159

Tetrahedron, 2001
Robert Saf, Herfried Griengl
exaly  

Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors

Frontiers in Cell and Developmental Biology, 2020
Kai Sun, , Liping Wang
exaly  

Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types

Annals of Oncology, 2018
MIGUEL A Molina-Vila, Manel Juan, Adela Rodríguez   +2 more
exaly  

Resistance to PD1/PDL1 checkpoint inhibition

Cancer Treatment Reviews, 2017
Mark Smyth, Georgina V Long, Richard Scolyer   +2 more
exaly  

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma

Annals of Oncology, 2017
Alexander M Menzies, Georgina V Long, Helen Rizos   +2 more
exaly  

Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma

Journal of Bone Oncology, 2020
Yuxuan Chen, Junlong Wu
exaly  

The diverse functions of the PD1 inhibitory pathway

Nature Reviews Immunology, 2017
Kristen E Pauken, Arlene Sharpe, Pauken Kristen E   +2 more
exaly  

Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients

OncoImmunology, 2018
Tao Zhou, Jiafu Ji, Xiaohong Wang
exaly  

Clinical blockade of PD1 and LAG3 — potential mechanisms of action

Nature Reviews Immunology, 2014
Pamela S Ohashi, Linh T Nguyen, Nguyen Linh T   +2 more
exaly  

A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease

Neurobiology of Aging, 2012
Mario Clerici, Federica Piancone, Marina Saresella   +2 more
exaly